Raymond Sanchez

机构：The University of Texas MD Anderson Cancer Center, Brown University, Allen Institute, SV Health Investors (United States)

发表论文 91 篇 · 总被引 4857 次 · h-index 34

代表论文

Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain (2017 · Journal of Pain and Symptom Management · 被引 237)
Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies (2017 · British Journal of Pain · 被引 179)
Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents (2017 · Journal of Child and Adolescent Psychopharmacology · 被引 130)
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial (2022 · The Lancet · 被引 113)
A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Fixed-Dose Brexpiprazole 2 mg/d as Adjunctive Treatment of Adults With Major Depressive Disorder (2018 · The Journal of Clinical Psychiatry · 被引 68)
Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study (2018 · Current Medical Research and Opinion · 被引 63)